Publications by authors named "M Soergel"

Claim this Profile
T
The Designed Ankyrin Repeat Protein Antiviral Ensovibep for Nonhospitalized Patients With Coronavirus Disease 2019: Results From EMPATHY, a Randomized, Placebo-Controlled Phase 2 Study.
Jeff Kingsley, Nagalingeswaran Kumarasamy, Luis Abrishamian, Marc Bonten, Awawu Igbinadolor, Marianne Soergel

Open Forum Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inferring the diurnal variability of OH radical concentrations over the Amazon from BVOC measurements.
A Ringsdorf, A Edtbauer, J Vilà-Guerau de Arellano, E Y Pfannerstill, S Gromov, M Soergel

Sci Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ensovibep, a SARS-CoV-2 antiviral designed ankyrin repeat protein, is safe and well tolerated in healthy volunteers: Results of a first-in-human, ascending single-dose Phase 1 study.
Nina Stojcheva, Stacy Gladman, Marianne Soergel, Christof Zitt, Roxana Drake

Br J Clin Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation study.
Manon L M Prins, Johan L van der Plas, Maurits F J M Vissers, Cécile L Berends, Gaby Tresch, Marianne Soergel

Br J Clin Pharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects.
Dénes Csonka, Shirin Bruderer, Armin Schultz, Marianne Soergel, Radka Stepanova

Clin Drug Investig· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis